ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,704.33
      -0.16%
      US Tech 100
      19,290.80
      -0.23%
      Dow Jones
      42,097.04
      0.17%
      Brent Oil
      74.285
      -0.05%
      Bitcoin
      62,669.07
      -0.45%
      Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Pulse Biosciences Inc (PLSE)

      7. Pulse Biosciences Inc (PLSE) News

      PLSE

      Pulse Biosciences (PLSE)

      Pulse Biosciences Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:PLSE
      DateTimeSourceHeadlineSymbolCompany
      08/19/20244:25PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:PLSEPulse Biosciences Inc
      08/15/20244:18PMEdgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBNASDAQ:PLSEPulse Biosciences Inc
      08/12/20245:10PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:PLSEPulse Biosciences Inc
      08/12/20244:15PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:PLSEPulse Biosciences Inc
      08/12/20244:05PMBusiness WirePulse Biosciences Reports Business Updates and Preliminary Second Quarter 2024 Financial ResultsNASDAQ:PLSEPulse Biosciences Inc
      08/12/20244:01PMBusiness WirePulse Biosciences, Inc. Appoints Paul LaViolette to Its Board of DirectorsNASDAQ:PLSEPulse Biosciences Inc
      08/08/20249:09AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:PLSEPulse Biosciences Inc
      08/08/20248:00AMBusiness WirePulse Biosciences, Inc. Announces Successful Treatment of Patients in First-in-Human Study with its Nano-PFA Cardiac Surgery SystemNASDAQ:PLSEPulse Biosciences Inc
      08/01/20244:05PMBusiness WirePulse Biosciences, Inc. Announces Participation in Upcoming Investor ConferencesNASDAQ:PLSEPulse Biosciences Inc
      07/29/20244:05PMBusiness WirePulse Biosciences Schedules Second Quarter 2024 Financial Results Conference Call for August 12, 2024NASDAQ:PLSEPulse Biosciences Inc
      07/22/20249:06PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PLSEPulse Biosciences Inc
      07/15/20247:10AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:PLSEPulse Biosciences Inc
      07/15/20247:04AMEdgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:PLSEPulse Biosciences Inc
      07/15/20246:05AMEdgar (US Regulatory)Form S-3MEF - Registration adding securities to prior Form S-3 registration [Rule 462(b)]NASDAQ:PLSEPulse Biosciences Inc
      07/09/20249:12AMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PLSEPulse Biosciences Inc
      07/08/20249:56PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PLSEPulse Biosciences Inc
      07/08/20249:54PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PLSEPulse Biosciences Inc
      07/08/20244:13PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:PLSEPulse Biosciences Inc
      07/08/20248:00AMBusiness WirePulse Biosciences, Inc. Announces Receipt of FDA Breakthrough Device Designation for CellFX® nsPFA Cardiac Surgery System for the Treatment of Atrial FibrillationNASDAQ:PLSEPulse Biosciences Inc
      07/03/20242:44PMBusiness WirePulse Biosciences, Inc. Announces the Closing of its Rights OfferingNASDAQ:PLSEPulse Biosciences Inc
      06/28/20248:00AMBusiness WirePulse Biosciences, Inc. Announces Preliminary Results for its Rights OfferingNASDAQ:PLSEPulse Biosciences Inc
      06/07/20244:16PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:PLSEPulse Biosciences Inc
      06/04/20244:05PMEdgar (US Regulatory)Form 424B2 - Prospectus [Rule 424(b)(2)]NASDAQ:PLSEPulse Biosciences Inc
      06/04/20244:04PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:PLSEPulse Biosciences Inc
      06/03/202412:15AMEdgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:PLSEPulse Biosciences Inc
      05/31/20244:18PMEdgar (US Regulatory)Form SD - Specialized disclosure reportNASDAQ:PLSEPulse Biosciences Inc
      05/28/20245:19PMEdgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementNASDAQ:PLSEPulse Biosciences Inc
      05/22/20242:07PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PLSEPulse Biosciences Inc
      05/22/20242:03PMEdgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:PLSEPulse Biosciences Inc
      05/20/20244:10PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:PLSEPulse Biosciences Inc
       Showing the most relevant articles for your search:NASDAQ:PLSE